Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MARK R PIPHER

Podiatric Medicine & Surgery Service Providers Podiatrist Foot & Ankle Surgery

NPI
1932356805
CMS profile
360753
Location
MESA, AZ

General Payments · PY2018–2024

$4,822.64

  • Reported across 188 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$751.17

35 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $751.17 35

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $265.55 10
Averitas Pharma Inc. $178.30 9
Bioventus LLC $67.32 3
Paratek Pharmaceuticals, Inc. $61.08 4
Smith & Nephew, Inc. $47.90 2
Amgen Inc. $41.51 2
ImpactOrtho, Inc. $25.71 1
Advanced Oxygen Therapy Inc. $22.74 2
Solventum Corporation $22.24 1
Innovation Technologies Inc $18.82 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $407.37 24
PY2019 $862.54 40
PY2020 $313.98 10
PY2021 $1,099.71 31
PY2022 $483.18 25
PY2023 $904.69 23
PY2024 $751.17 35

Payment records · PY2024 (35)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $26.05 01/11/2024 Food and Beverage Undisputed 01/23/2026 1105274717 CMS
ABBVIE INC. $28.42 02/21/2024 Food and Beverage Undisputed 01/23/2026 1105274721 CMS
ABBVIE INC. $18.97 04/17/2024 Food and Beverage Undisputed 01/23/2026 1105274725 CMS
ABBVIE INC. $24.00 04/18/2024 Food and Beverage Undisputed 01/23/2026 1105274729 CMS
ABBVIE INC. $30.31 05/30/2024 Food and Beverage Undisputed 01/23/2026 1105274733 CMS
ABBVIE INC. $23.89 08/19/2024 Food and Beverage Undisputed 01/23/2026 1105274738 CMS
ABBVIE INC. $28.40 09/19/2024 Food and Beverage Undisputed 01/23/2026 1105274743 CMS
ABBVIE INC. $30.43 10/09/2024 Food and Beverage Undisputed 01/23/2026 1105274747 CMS
ABBVIE INC. $32.76 11/12/2024 Food and Beverage Undisputed 01/23/2026 1105274751 CMS
ABBVIE INC. $22.32 12/05/2024 Food and Beverage Undisputed 01/23/2026 1105274755 CMS
Advanced Oxygen Therapy Inc. $13.97 06/21/2024 Food and Beverage Undisputed 01/23/2026 1111764584 CMS
Advanced Oxygen Therapy Inc. $8.77 09/24/2024 Food and Beverage Undisputed 01/23/2026 1117467301 CMS
Amgen Inc. $17.57 07/25/2024 Food and Beverage Undisputed 01/23/2026 1111677601 CMS
Amgen Inc. $23.94 10/24/2024 Food and Beverage Undisputed 01/23/2026 1111677603 CMS
Averitas Pharma Inc. $22.30 02/20/2024 Food and Beverage Undisputed 01/23/2026 1133441506 CMS
Averitas Pharma Inc. $7.03 04/09/2024 Food and Beverage Undisputed 01/23/2026 1133441510 CMS
Averitas Pharma Inc. $27.09 04/29/2024 Food and Beverage Undisputed 01/23/2026 1133441513 CMS
Averitas Pharma Inc. $8.42 06/12/2024 Food and Beverage Undisputed 01/23/2026 1133441518 CMS
Averitas Pharma Inc. $24.58 07/18/2024 Food and Beverage Undisputed 01/23/2026 1133441522 CMS
Averitas Pharma Inc. $33.61 09/04/2024 Food and Beverage Undisputed 01/23/2026 1133441526 CMS
Averitas Pharma Inc. $23.68 10/11/2024 Food and Beverage Undisputed 01/23/2026 1133441530 CMS
Averitas Pharma Inc. $3.55 10/11/2024 Food and Beverage Undisputed 01/23/2026 1133441534 CMS
Averitas Pharma Inc. $28.04 12/19/2024 Food and Beverage Undisputed 01/23/2026 1133441539 CMS
Bioventus LLC $25.67 01/30/2024 Food and Beverage Undisputed 01/23/2026 1137447333 CMS
Bioventus LLC $17.92 04/30/2024 Food and Beverage Undisputed 01/23/2026 1137447335 CMS
Bioventus LLC $23.73 07/23/2024 Food and Beverage Undisputed 01/23/2026 1137447337 CMS
ImpactOrtho, Inc. $25.71 12/09/2024 Food and Beverage Undisputed 01/23/2026 1124796561 CMS
Innovation Technologies Inc $18.82 06/17/2024 Food and Beverage Undisputed 01/23/2026 1130823194 CMS
Paratek Pharmaceuticals, Inc. $13.82 06/24/2024 Food and Beverage Undisputed 01/23/2026 1113914409 CMS
Paratek Pharmaceuticals, Inc. $14.18 07/09/2024 Food and Beverage Undisputed 01/23/2026 1113914411 CMS
Paratek Pharmaceuticals, Inc. $17.66 09/05/2024 Food and Beverage Undisputed 01/23/2026 1113914413 CMS
Paratek Pharmaceuticals, Inc. $15.42 11/07/2024 Food and Beverage Undisputed 01/23/2026 1113914415 CMS
Smith+Nephew, Inc. $24.43 10/31/2024 Food and Beverage Undisputed 01/23/2026 1149495169 CMS
Smith+Nephew, Inc. $23.47 11/15/2024 Food and Beverage Undisputed 01/23/2026 1149495167 CMS
Solventum Corporation $22.24 08/05/2024 Food and Beverage Undisputed 01/23/2026 1144061182 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.